OMCL:NGS-Omnicell Inc. (USD)

EQUITY | Health Information Services | Nasdaq Global Select

Last Closing

USD 30.28

Change

-0.52 (-1.69)%

Market Cap

USD 1.28B

Volume

0.51M

Analyst Target

USD 81.29
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Omnicell Inc provides automation and business analytics software solutions for patient-centric medication and supplies management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-14 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

-1.10 (-1.38%)

USD 37.23B
HQY HealthEquity Inc

-0.08 (-0.10%)

USD 6.90B
RCM R1 RCM Inc

+0.27 (+2.16%)

USD 5.26B
TXG 10X Genomics Inc

+0.11 (+0.49%)

USD 3.06B
CERT Certara Inc

-0.07 (-0.42%)

USD 2.69B
GDRX Goodrx Holdings Inc

+0.13 (+1.82%)

USD 2.68B
PGNY Progyny Inc

-0.33 (-1.22%)

USD 2.62B
PRVA Privia Health Group Inc

-0.03 (-0.17%)

USD 2.07B
PINC Premier Inc

-0.05 (-0.26%)

USD 1.99B
BTSG BrightSpring Health Services I..

-0.04 (-0.35%)

USD 1.95B

ETFs Containing OMCL

HTEC Robo Global® Healthcare .. 1.94 % 0.00 %

-0.22 (-1.07%)

USD 0.06B
DOCG:LSE L&G Healthcare Breakthrou.. 1.90 % 0.00 %

-11.10 (-1.07%)

USD 0.07B
DOCT:LSE L&G Healthcare Breakthrou.. 1.90 % 0.00 %

-0.12 (-1.07%)

USD 0.07B
ROBO Robo Global® Robotics an.. 1.82 % 0.00 %

-0.12 (-1.07%)

USD 1.27B
ROBO Robo Global® Robotics an.. 1.82 % 0.95 %

-0.12 (-1.07%)

USD 1.27B
ROBE:LSE L&G ROBO Global Robotics .. 1.80 % 0.00 %

-0.06 (-1.07%)

USD 0.84B
ROBG:LSE L&G ROBO Global Robotics .. 1.80 % 0.00 %

-7.00 (-1.07%)

USD 0.84B
ROBO:LSE Legal & General UCITS ETF.. 1.80 % 0.00 %

-0.01 (-1.07%)

USD 0.84B
SDD ProShares UltraShort Smal.. 0.46 % 0.95 %

+0.13 (+-1.07%)

USD 2.28M
SBB ProShares Short SmallCap6.. 0.00 % 0.95 %

+0.06 (+-1.07%)

USD 5.90M
DMRS 0.00 % 0.45 %

N/A

N/A
IJR:AU iShares Core S&P SmallCap.. 0.00 % 0.00 %

N/A

USD 0.54B
ROBO:AU ETFS ROBO Global Robotics.. 0.00 % 0.00 %

N/A

USD 0.25B

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -19.53% 52% F 25% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -19.53% 52% F 25% F
Trailing 12 Months  
Capital Gain -56.87% 35% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -56.87% 35% F 15% F
Trailing 5 Years  
Capital Gain -62.70% 28% F 22% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -62.70% 28% F 21% F
Average Annual (5 Year Horizon)  
Capital Gain 1.86% 69% C- 51% F
Dividend Return 1.86% 69% C- 47% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 59.68% 16% F 27% F
Risk Adjusted Return 3.12% 69% C- 43% F
Market Capitalization 1.28B 78% C+ 75% C

Key Financial Ratios

  Ratio vs. Industry/Classification (Health Information Services) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 158.60 9% 3%
Price/Book Ratio 1.05 67% 68%
Price / Cash Flow Ratio 7.06 41% 33%
Price/Free Cash Flow Ratio 22.79 14% 11%
Management Effectiveness  
Return on Equity -1.76% 77% 57%
Return on Invested Capital -2.03% 71% 52%
Return on Assets -0.61% 77% 57%
Debt to Equity Ratio 47.91% 38% 42%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector